Search
for
Sort by
Research 61–90 of 1000+
- Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites
- Estrogen and androgen signaling in the pathogenesis of BPH
- The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- A Role for Steroid 5 alpha-reductase 1 in Vascular Remodelling During Endometrial Decidualisation
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- In Search of Predictive Models for Inhibitors of 5-alpha Reductase 2 Based on the Integration of Bioactivity and Molecular Descriptors Data.
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase